Personalized management of hepatocellular carcinoma based on molecular information: future prospects
- PMID: 26213619
- PMCID: PMC4512174
- DOI: 10.1002/cld.483
Personalized management of hepatocellular carcinoma based on molecular information: future prospects
Figures



Similar articles
-
Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.Int Surg. 2014 Nov-Dec;99(6):779-86. doi: 10.9738/INTSURG-D-13-00122.1. Int Surg. 2014. PMID: 25437587 Free PMC article. Review.
-
Time for paradigm change in management of hepatocellular carcinoma: is a personalized approach on the horizon?Per Med. 2016 Sep;13(5):455-467. doi: 10.2217/pme-2016-0013. Epub 2016 Jul 27. Per Med. 2016. PMID: 29767598
-
Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects.World J Gastroenterol. 2019 Aug 28;25(32):4682-4695. doi: 10.3748/wjg.v25.i32.4682. World J Gastroenterol. 2019. PMID: 31528094 Free PMC article. Review.
-
Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.Cancer Chemother Pharmacol. 1982;8(2):231-5. doi: 10.1007/BF00255489. Cancer Chemother Pharmacol. 1982. PMID: 6286165 Review.
-
Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response.Surg Oncol. 2017 Jun;26(2):138-145. doi: 10.1016/j.suronc.2017.01.009. Epub 2017 Feb 21. Surg Oncol. 2017. PMID: 28577719 Review.
Cited by
-
Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus.Transl Oncol. 2018 Apr;11(2):511-517. doi: 10.1016/j.tranon.2018.02.015. Epub 2018 Mar 7. Transl Oncol. 2018. PMID: 29524828 Free PMC article.
-
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.Hepatoma Res. 2018;4:1. doi: 10.20517/2394-5079.2017.46. Epub 2018 Jan 12. Hepatoma Res. 2018. PMID: 29376136 Free PMC article.
References
-
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29. - PubMed
-
- Michelotti GA, Machado MV, Diehl AM. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 2013;10:656–665. - PubMed
-
- Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 2014;59:2188–2195. - PubMed
-
- Oda K, Uto H, Mawatari S, Ido A. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. Clin J Gastroenterol 2015;8:1–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources